The purpose of the Sidney Kimmel Comprehensive Cancer Center (SKCCC) Cancer Functional Imaging Core (CFIC) is to integrate state-of-the-art noninvasive imaging capabilities to advance the translational research mission of SKCCC members. Within the past five, years the Core has significantly expanded to include an Olympus multiphoton microscope for in vivo imaging, a LI-COR Pearl imager, a SuperArgus PET/CT scanner and a Vector SPECT/PET scanner. These are in addition to the existing 9.4T Bruker horizontal bore MR scanner, Kodak and Xenogen optical imaging systems, a Gamma-Medica CT/SPECT and an Argus PET imaging system, and a VisualSonics ultrasound imaging system. The equipment is housed in a 2,400 ft2 small- animal imaging facility in Miller Research Building (MRB), overseen by dedicated technical staff members. These Cancer Functional Imaging Core facilities provide SKCCC members with advanced small-animal imaging capabilities that result in high-impact peer-reviewed publications and research funding. These imaging techniques are translatable into the clinic, providing imaging data in small animals used to develop translational applications in humans. Zaver M. Bhujwalla, Ph.D., is the Director of the Cancer Functional Imaging Core. She is also Program Co- Leader of the SKCCC Cancer Molecular and Functional Imaging Program and the Director of the Johns Hopkins University ICMIC (In Vivo Cellular Molecular Imaging Center) Program. Dr. Bhujwalla directs a newly created Division of Cancer Imaging Research in the Department of Radiology and Radiological Science. Dr. Bhujwalla has an outstanding track record in molecular imaging applications in cancer. The two Associate Directors, Martin G. Pomper, M.D., Ph.D., and Dmitri Artemov, Ph.D., are well-known investigators who played a key role in the establishment of molecular imaging at The Johns Hopkins University (JHU). Dr. Pomper directs the Division of Nuclear Medicine and Molecular Imaging. He is also Co-Leader of the SKCCC Cancer Molecular and Functional Imaging Program and Associate Director of the JHU ICMIC. SKCCC Managed Core Reporting Period: Jan. 1, 2015, to Dec. 31, 2015

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA006973-54
Application #
9278336
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2017-05-01
Budget End
2018-04-30
Support Year
54
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Bastos, Diogo A; Antonarakis, Emmanuel S (2018) AR-V7 and treatment selection in advanced prostate cancer: are we there yet? Precis Cancer Med 1:
Stein-O'Brien, Genevieve; Kagohara, Luciane T; Li, Sijia et al. (2018) Integrated time course omics analysis distinguishes immediate therapeutic response from acquired resistance. Genome Med 10:37
Dean, Lorraine T; Montgomery, Madeline C; Raifman, Julia et al. (2018) The Affordability of Providing Sexually Transmitted Disease Services at a Safety-net Clinic. Am J Prev Med 54:552-558
Mondul, Alison M; Joshu, Corinne E; Barber, John R et al. (2018) Longer-term Lipid-lowering Drug Use and Risk of Incident and Fatal Prostate Cancer in Black and White Men in the ARIC Study. Cancer Prev Res (Phila) 11:779-788
Lu, Dai-Yin; Yalçin, Hulya; Yalçin, Fatih et al. (2018) Stress Myocardial Blood Flow Heterogeneity Is a Positron Emission Tomography Biomarker of Ventricular Arrhythmias in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol 121:1081-1089
Brundage, Michael; Blackford, Amanda; Tolbert, Elliott et al. (2018) Presenting comparative study PRO results to clinicians and researchers: beyond the eye of the beholder. Qual Life Res 27:75-90
Woodard, Lauren E; Dennis, Cindi L; Borchers, Julie A et al. (2018) Nanoparticle architecture preserves magnetic properties during coating to enable robust multi-modal functionality. Sci Rep 8:12706
Shrestha, Eva; White, James R; Yu, Shu-Han et al. (2018) Profiling the Urinary Microbiome in Men with Positive versus Negative Biopsies for Prostate Cancer. J Urol 199:161-171
Gordy, James T; Luo, Kun; Francica, Brian et al. (2018) Anti-IL-10-mediated Enhancement of Antitumor Efficacy of a Dendritic Cell-targeting MIP3?-gp100 Vaccine in the B16F10 Mouse Melanoma Model Is Dependent on Type I Interferons. J Immunother 41:181-189
El-Diwany, Ramy; Soliman, Mary; Sugawara, Sho et al. (2018) CMPK2 and BCL-G are associated with type 1 interferon-induced HIV restriction in humans. Sci Adv 4:eaat0843

Showing the most recent 10 out of 2393 publications